2020 Chinese guidelines for ultrasound malignancy risk stratification of thyroid nodules: the C-TIRADS

Jianqiao Zhou ,Liu Hongmin ,Pi Yanmin ,Xiaojie Pan ,Qinying Li ,Chen Wu ,Tao You ,Wu Qing ,Shu-E Zeng ,Hongtian Chen ,Jingbin Yan ,Yu Liang ,Ligang Cui ,Jie Yang ,Yali Wang ,Zhu Zheng ,Cai Yuanjin ,Qing Shunhua ,Changjun Wu ,Feng Li ,Fang Chao ,Wenjun Zhang ,Yukun Luo ,Man Lu ,Tao Chen ,Lichun Yang ,Nima Yuzhen ,Guosheng Liang ,Jiping Yan ,Zhang Na ,Ling Jia ,Shaoyun Hao ,Huang Dao-Zhong ,Che Guihua ,Wang Zhaorui ,Chengrong Mi ,Wu Zhiling ,Zhengdong Fei ,Peng Zhou ,Jie Tang ,Yingjia Li ,Wei Wang ,Wen Chen ,Hui Zhang ,Jianlei Zhang ,Xinguang Chen ,Shaozheng He ,Hong Zhou ,Wu Wenjing ,Cui Guanghe ,Miao Juan ,Jie Hu ,Xue Dong ,Ru Rongrong ,Renaguli Aisha ,Yuhua Zhang ,Huang Peipei ,Huiwen Li ,Jia Liu ,Su Demin ,Beijian Huang ,Kexin Lou ,Liang Wu ,Dai Liping ,Jianchu Li ,Xuejun Ni ,Tingyue Qi ,Liang Bao ,Lei Shi ,Wu Haiyan ,Kong Xiangchong ,Ze Liang ,Chen Fu ,Li Xingyun ,Xi Wei ,Xinhua Ye ,Yansha Deng ,Chen Hui-Pin ,Xinhui Jiang ,Jiehuan Chen ,Bin Zhu ,Xiaofeng He ,Jie Lin ,Ruifang Zhang ,Zizhen Zhang ,Sheng Zhang ,Tang Li Na ,Ren Jinhe ,Jing Li ,Yibo Zhou ,Hu Liyan ,Feng Zhao ,Chaoyang Wen ,Li Huang ,Sun Anyi ,Qiaoying Li ,Fengkai Fang ,Chuanyin Li ,Xiuping Chen ,Dong Liu ,Qingya Yang ,Wei Zhan ,Hongyan Chen ,Yang Jianqing ,Yun Pang ,Yingchun Wang ,Yuanyi Zheng ,Huang Jianyuan ,Panpan Zhang ,Wu Ting ,Sun Zhuogui ,Li Chen ,Yuan Zhihong ,Yehu Lu ,Yuan Hui ,Yan Zhang ,Jianli Wu ,Ruhai Zhou ,Weiwei Huang ,Kang Hj ,Yanchao Liu ,Linxue Qian ,Wu Zhongqiu ,Wang Yuansheng ,Lei Xiaoqing ,Xiaoqing Yang ,Huang Dingwei ,Xian‐Li Zhou ,Yang Xuewen ,Mei Zhu ,Fu Jian ,Long Yin ,Tao Shen ,Lina Guan ,Xuedong Deng ,Qin Chen ,Ensheng Xue ,Yanqing Wang ,Linsong Wu ,Jie Shi ,Yanbin Wang ,Chen Nianqiao ,Jingchun Yang ,Jianxin Li ,Fang Wang ,Peng Mei ,Na Zhou ,Yang Yingmei ,Xiaoling Yu ,Jian Zhang ,Qin Qianmiao ,Gang Du ,Song Liu ,Huijuan Xiang ,Ning Li ,Xiaodong Zhang ,Ying Zhu ,Zhu Lisha ,Yun‐Fei Zhang ,Gang Wu ,Jian Wu ,Haiyan Li ,Liu K ,Zhao Li ,Shibao Fang ,Shi Hongwei ,Yulan Peng ,Li Anyang ,Jiaan Zhu ,Xin Chang ,Lei Zhang ,Wang Li ,Tang Binhui ,Lili Dong ,Lili Zhang ,Xiao Lifang ,Yue Chen ,Jing Wang ,Yanzhen Wang ,Feng Mao ,Yongping Lu ,Tong Zhang ,Jian Wang ,Rong Wu ,Yanyan Song ,Hou Aiqin ,Xinfang Wang ,Qu Jian-Feng ,Tao Wu ,Haitao Ran ,Tao Li ,Bin Bai ,Peng Zhenyi ,Yang Yinguang ,Peng-Fei Zhang ,Lijuan Zhang ,Hongmei Li ,Yan Yang ,Jinping Wang ,Qiang Xu ,Shou Jinduo ,Guoqing Du ,Qing Wan ,Yuquan Ye ,Na He ,Baoming Luo ,Xie Chuanwen ,Yu Zhao ,Wendong Li ,Yuhong Zhang ,Huaxuan Wen ,Renhua Guo ,Wei Zhou ,Jun Guo ,Min Chen ,Li Cheng ,Xianhe Xie ,Aihua Liu ,Zou Bao

doi:10.1007/s12020-020-02441-y

Abstract

Thyroid nodules are very common all over the world, and China is no exception. Ultrasound plays an important role in determining the risk stratification of thyroid nodules, which is critical for clinical management of thyroid nodules. For the past few years, many versions of TIRADS (Thyroid Imaging Reporting and Data System) have been put forward by several institutions with the aim to identify whether nodules require fine-needle biopsy or ultrasound follow-up. However, no version of TIRADS has been widely adopted worldwide till date. In China, as many as ten versions of TIRADS have been used in different hospitals nationwide, causing a lot of confusion. With the support of the Superficial Organ and Vascular Ultrasound Group of the Society of Ultrasound in Medicine of the Chinese Medical Association, the Chinese-TIRADS that is in line with China's national conditions and medical status was established based on literature review, expert consensus, and multicenter data provided by the Chinese Artificial Intelligence Alliance for Thyroid and Breast Ultrasound.

Full Text